SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013

Clin Transl Oncol. 2013 Dec;15(12):1018-24. doi: 10.1007/s12094-013-1096-z. Epub 2013 Aug 27.

Abstract

Head and neck cancer represents 5 % of oncologic cases in adults. Early stage treatments are local with surgery and/or radiotherapy. For locally advanced stages, treatment requires radiotherapy combined with platinum-based drugs or cetuximab. Induction chemotherapy should be considered for selected cases. In the case of metastatic disease, adjuvant or palliative treatment is based on platinum agents and cetuximab.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Algorithms
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cetuximab
  • Drug Administration Schedule
  • Head and Neck Neoplasms / diagnosis
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Induction Chemotherapy / standards
  • Neoplasm Metastasis
  • Neoplasm Staging / standards

Substances

  • Antibodies, Monoclonal, Humanized
  • Cetuximab